ALSO: Iambic files for a Nasdaq IPO into a rebounding market; Up to $1.4B for desining oral macrocycles with AI; Stanford researchers turn manuscripts into AI agents that collaborate, and more...
Weekly Tech+Bio #85: Big Pharma Is Betting On…
ALSO: Iambic files for a Nasdaq IPO into a rebounding market; Up to $1.4B for desining oral macrocycles with AI; Stanford researchers turn manuscripts into AI agents that collaborate, and more...